LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

Myocor (Acquired)

Minimally-invasive cardiac implantable devices for treating mitral valve regurgitation without atriotomy or cardiopulmonary bypass.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Myocor (Acquired) plus 6123 other startups.

Learn More About Myocor (Acquired)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More